Results 211 to 220 of about 612,801 (299)
Direct-Acting Antivirals Are a Milestone for Hepatitis C Virus Infection? Analysis of 15 Years of Patient and Diagnosis Data from a Region in Türkiye. [PDF]
Yakupogullari Y, Tanrıverdi ES, Otlu B.
europepmc +1 more source
Engineered extracellular vesicles (EVs) offer a versatile platform for kidney‐targeted therapy. This review summarizes bioengineering strategies, including cargo loading, surface modification, biomimetic fabrication, and biomaterial integration. We highlight translational challenges and propose future solutions to accelerate the clinical application of
Linru Shi +6 more
wiley +1 more source
Hepatitis C virus genotype 4 cluster with suspected sexual transmission in Chicago, IL. [PDF]
Holly T +8 more
europepmc +1 more source
This review illustrates how scientists engineer exosomes by hijacking the cell's own cargo‐sorting machinery. These strategies efficiently load therapeutic molecules into natural vesicles, creating powerful next‐generation drug delivery systems (Created with BioGDP.com).
Huanrong Zhu +6 more
wiley +1 more source
Correction: Hepatitis C virus cascade of care among adults in Sindh province, Pakistan: Findings from 2019-2020 household sero-survey. [PDF]
Alamneh TS +9 more
europepmc +1 more source
Primary hepatic cancer (PHC), especially hepatocellular carcinoma (HCC), is still a significant burden worldwide. The efficacy of diagnosis, treatment response monitoring, and prognostication using laboratory biomarkers is still a challenge. This study analyzed multi‐laboratory parameters pre‐ and post‐treatment and their associations with clinical and
Xiaowei Chi +3 more
wiley +1 more source
Co-infection with hepatitis B virus and hepatitis C virus
Heloísa Pedrosa Mitre +1 more
doaj +1 more source
Serological and molecular detection of hepatitis C virus in Amran governorate, Yemen. [PDF]
Al-Hadheq AA +8 more
europepmc +1 more source

